IgG Biomarkers in Multiple Sclerosis: Deciphering Their Puzzling Protein A Connection

Area of Science:

• Neuroimmunology
• Biomarker Discovery

Background:

• Cerebrospinal fluid (CSF) sampling is invasive for multiple sclerosis (MS) diagnosis.
• Peripheral blood biomarkers for MS are underdeveloped.
• B cells and immunoglobulins (Igs) are key areas of investigation.

Purpose of the Study:

• To explore B cells and immunoglobulins as potential MS biomarkers.
• To investigate novel IgG aggregates found in MS blood.
• To assess the diagnostic potential of these aggregates.

Main Methods:

• Review of existing literature on B cells and Igs in MS.
• Analysis of novel IgG aggregates in MS patient blood samples.
• Enzyme-linked immunosorbent assay (ELISA) to evaluate aggregate diagnostic accuracy.

Main Results:

• MS patients exhibit unique blood IgG aggregates that do not bind Protein A.
• These aggregates, enriched in IgG1/IgG3, have mutations in IGHV3 FR3 and drive complement-dependent neuronal apoptosis.
• ELISA data show high accuracy in distinguishing MS patients from controls and other CNS disorders.

Conclusions:

• Novel IgG aggregates in peripheral blood represent promising non-invasive biomarkers for MS diagnosis.
• These biomarkers may aid in monitoring disease activity and differentiating MS subtypes.
• Further research into IgG aggregates could advance MS management.